Digoxin vs Durvalumab

## Digoxin vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Digoxin** and **Durvalumab**.

## Mechanism of Action

**Digoxin**: Inhibits Na+/K+-ATPase, increasing intracellular calcium.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Digoxin — 36-48 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Digoxin — C41H64O14; Durvalumab — N/A.

**Molecular Weight**: Digoxin — 780.9430 g/mol; Durvalumab — N/A.

**Type**: Digoxin — Small molecule; Durvalumab — Antibody.